Apushkin, Marsha

Apushkin, Marsha was paid $1.00M by Medicaid between Jan 2018 and Nov 2024, across 118 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 18% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#64 of 398

Median peer was paid$66K

This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	512	$7K
2019	725	$13K
2020	532	$12K
2021	475	$17K
2022	445	$18K
2023	30,656	$238K
2024incomplete	80,629	$695K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	18%	3,487	2,851	$177K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	17%	3,457	3,080	$169K
88305	Level IV - Surgical pathology, gross and microscopic examination	7.6%	2,639	2,242	$76K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	5.4%	1,808	1,547	$54K
85027		4.5%	15,687	9,509	$45K
80053	Comprehensive metabolic panel	4.3%	8,337	5,872	$43K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	3.5%	121	108	$35K
80048	Basic metabolic panel (calcium, ionized)	2.5%	6,153	3,547	$25K
82805		2.5%	1,342	462	$25K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	2.0%	715	643	$20K
83880		1.9%	1,552	1,168	$19K
84443	Thyroid stimulating hormone (TSH)	1.7%	2,077	1,798	$17K

106 more codes

88307		1.6%	337	$16K
87400		1.6%	2,058	$16K
84484		1.5%	3,376	$15K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	1.5%	84	$15K
86480		1.4%	518	$14K
83735		1.3%	4,065	$13K
86703		1.2%	1,467	$12K
83036	Hemoglobin; glycosylated (A1C)	1.0%	3,136	$10K
82948		<1%	4,429	$9K
80061	Lipid panel	<1%	2,829	$9K
83690		<1%	2,501	$8K
81025		<1%	3,162	$8K
83605		<1%	1,441	$7K
87040		<1%	762	$7K
85610		<1%	3,686	$7K
85730		<1%	2,229	$7K
87430		<1%	826	$6K
87340		<1%	1,091	$6K
80074		<1%	309	$6K
81000		<1%	4,477	$6K
82607		<1%	787	$5K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	541	$5K
85384		<1%	1,371	$4K
84702		<1%	882	$4K
86592		<1%	2,084	$4K
87088		<1%	852	$4K
82550		<1%	1,597	$3K
88312		<1%	166	$3K
86803		<1%	451	$3K
87480		<1%	238	$3K
87510		<1%	238	$3K
83655		<1%	469	$3K
88304		<1%	163	$3K
84100		<1%	1,892	$3K
80164		<1%	550	$2K
86850		<1%	740	$2K
84439		<1%	494	$2K
83020		<1%	240	$2K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	267	$2K
82728		<1%	473	$2K
85379		<1%	517	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	72	$2K
87081		<1%	584	$2K
82553		<1%	405	$2K
84436		<1%	488	$2K
80076		<1%	450	$1K
83540		<1%	420	$1K
86900		<1%	813	$1K
88342		<1%	102	$1K
85007		<1%	636	$1K
80202		<1%	160	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	76	$1K
87420		<1%	143	$1K
88300		<1%	156	$1K
83550		<1%	276	$1K
85651		<1%	402	$888.30
86901		<1%	314	$712.80
82010		<1%	284	$707.14
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	313	$689.28
88160		<1%	33	$675.15
88141		<1%	137	$569.09
86762		<1%	125	$564.87
87186		<1%	112	$545.58
85660		<1%	227	$530.80
82747		<1%	72	$473.03
80185		<1%	68	$441.32
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	50	$440.00
84153		<1%	62	$402.60
87070		<1%	125	$399.90
86694		<1%	54	$366.85
82570		<1%	141	$361.39
82746		<1%	63	$340.94
84481		<1%	57	$289.56
82140		<1%	56	$285.60
84060		<1%	81	$279.94
84165		<1%	97	$264.28
86336		<1%	27	$245.78
83970		<1%	16	$238.07
86140		<1%	99	$231.01
82105		<1%	28	$221.67
80305		<1%	31	$208.94
86706		<1%	32	$203.78
82677		<1%	27	$203.02
80069		<1%	55	$200.71
82670		<1%	15	$146.70
83498		<1%	15	$142.65
82626		<1%	16	$141.60
83001		<1%	15	$136.35
82947		<1%	74	$135.61
85018		<1%	125	$129.92
82043		<1%	61	$120.09
84550		<1%	77	$113.44
85014		<1%	95	$112.52
87075		<1%	18	$106.74
83002		<1%	15	$97.20
87205		<1%	54	$94.50
82950		<1%	40	$93.20
86787		<1%	12	$90.16
82248		<1%	62	$83.04
86735		<1%	12	$76.20
82951		<1%	12	$75.60
80178		<1%	20	$71.06
83525		<1%	15	$66.45
84479		<1%	15	$47.85
82952		<1%	12	$26.74
36415	Collection of venous blood by venipuncture	0%	55	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.